Investors & Media

Stock Info
NASDAQBCLI
Company Information

BrainStorm (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD).

Brainstorm’s Alzheimer’s Key Opinion Leader Event

Brainstorm’s July 8, 2020 Key Opinion Leader (KOL) Webinar on the Company's Alzheimer's Disease (AD) Clinical Program.

Corresponding Presentation

Recent News
Oct 22, 2020

SOMERSET, N.J. and New York – October 22, 2020 — Catalent (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs,...

Oct 19, 2020

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, announced the presentation of a poster titled, "MSC-NTF...

Oct 15, 2020

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the third quarter ended September...

View All

Events
Monday, October 12, 2020 - Friday, October 16, 2020

View All

Email Alerts
Investor Contact
Investor FAQs
RSS Feeds